The discipline of medical mycology has become increasingly relevant in the face of the rising incidence of invasive fungal infections (IFI), which pose diagnostic and therapeutic challenges for contemporary medical practice. While firmly established in developed countries, medical mycology remains obscure in many low-and middleincome countries (LMICs). With a teeming vulnerable populace and an incidence rate 
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The discipline of medical mycology has become increasingly relevant in the face of the rising incidence of invasive fungal infections (IFI), which pose diagnostic and therapeutic challenges for contemporary medical practice. While firmly established in developed countries, medical mycology remains obscure in many low-and middleincome countries (LMICs). With a teeming vulnerable populace and an incidence rate of 11.8%, Nigeria has one of the highest estimated burdens of invasive fungal infections (IFIs) in the world. Regardless, the scourge of IFIs has remained silent due to a combination of factors principal amongst which are a lack of awareness and dearth in personnel skilled in diagnosis. The present narrative examines the status of medical mycology practice in Nigeria and chronicles the journey to change the status quo spurred by the Leading International Fungal Education (LIFE)-facilitated burden estimate paper and culminating in the birth of the Medical Mycology Society of Nigeria (MMSN), the pioneer national medical mycology society in Africa. The prospects of tackling the IFI challenge are highlighted from the perspective of the nascent society.
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| INTRODUC TI ON
In the last few decades, the incidence of invasive fungal infections (IFI) has risen due to an increase in the populations at risk. 1, 2 According to recent global estimates, more than 15 million cases of fungal infections occur annually. 3 More than 1.6 million people die of fungal diseases each year: 500 000 of these are AIDS-related and a further 450 000 are due to chronic pulmonary aspergillosis. 4, 5 These figures are likely an underestimation because autopsy rates have declined universally and successful ante-mortem diagnosis of IFIs does not exceed 50% even with the best diagnostic tools. 6, 7 Moreover, most countries lack a surveillance system for fungal infections. 
| HIS TORI C AL BACKG ROUND OF MED I C AL MYCOLOGY IN NI G ERIA PRI OR TO THE BURDEN E S TIMATE
H.C Gugnani is the principal documented source for the history of twentieth-century medical mycology practice in Nigeria. 15, 16 The discipline began in University College 
| BURDEN E S TIMATE OF IFIS IN NIG ERIA
The value of research often resides in its ability to bring about societal change. One such research endeavour can be said to have sparked a series of changes with the potential to alter the bleak picture painted in the preceding paragraph and is therefore cited as a landmark inflection point for medical mycology practice in 
| THE INVA S IVE FUNG AL INFEC TI ON FORUM AND E S TAB LIS HMENT OF MED I C AL MYCOLOGY SO CIE T Y OF NI G ERIA
In 2014, the invasive fungal infection forum (IFIF) was set up with the aim of bridging the knowledge gap and driving the awareness of IFIs in Nigeria. Annually, the forum organised training events targeted at specialist doctors who routinely manage patients at risk of seri- 
MMSN Study Group Activities
Histoplasmosis Study Group Completed a multicentre histoplasmin skin sensitivity survey of IFIs in Nigeria due to a scope that is too broad. This is evident in the themes from the annual conferences held so far which consistently focus on fungi in relation to the economy, agriculture and biotechnology. We believe the focus of the MMSN, first on medical mycology and secondly on Nigeria, make it doubly suited over these older professional bodies to impact health needs of the nation as it relates to IFIs.
| Prospects
A vibrant community with consistent activities and focused goals is necessary if the MMSN is to bring about the much needed renaissance in medical mycology practice in Nigeria.
| Community
The MMSN will continue to work to build up its membership to include clinical microbiologists and PhD diagnostic scientists, infectious disease physicians, respiratory disease physicians, radiologists, surgeons, pathologists, pharmacists and also other medical specialties including dermatologists, paediatricians, intensivists, oncologists and public health physicians. This is because IFIs are best researched and managed by multidisciplinary teams which integrate diagnostic and therapeutic decision making in a timely manner. 
| Activities
The activities undertaken by MMSN such as educational meetings, hands-on trainings, research, gap analysis surveys and development of guidelines will serve as tools to improve medical mycology practice in Nigeria and impact on outcome in management of the patient population at risk of these life-threatening IFIs.
Epidemiological studies to map disease distribution represent one of the first tasks of national medical mycology societies and are already a core mission of MMSN. Emphasis will be placed on nationally relevant IFIs as exemplified by the study groups of MMSN (Table 1 ). Data derived from these studies can facilitate the development of evidence-based diagnostic and therapeutic guidelines that are country-specific. They will also be needed to advocate for greater attention from government and support from multilateral agencies. Furthermore, dissemination in peer-reviewed journals will help drive awareness and clinical index of suspicion about IFIs amongst clinicians in Nigeria.
MMSN originated from focused educational programmes to address the knowledge gaps amongst practicing physicians and these will continue to be organised annually. Hands-on training to build laboratory diagnostic capacity will continue. The society plans to take 
| Goals
While improved awareness and capacity building are essential goals (Figure 1 ), the greatest dividends can perhaps be achieved with successful efforts at advocacy. MMSN intends to target advocacy efforts at the administrators of academic institutions, specialist physicians and most importantly the government.
With the results of gap analyses surveys in undergraduate and postgraduate training, recommendations will be made to administrators of universities and postgraduate training colleges to better emphasise mycology training in their respective curricula. This is a long-term goal. Likewise, surveys of local practices can inform the development of unified clinical management guidelines. Activism will be required to encourage specialists to adopt these guidelines.
We will also advocate that there is need for standardisation of medical mycology curriculum and training which should be driven internationally by ISHAM and ECMM. MMSN will also advocate for the government to partner with international bodies to facilitate the establishment and running of these reference laboratories, a model of which is the mycology reference laboratory in Chandigarh, India, which serves as a WHO collaborating centre.
• Training programmes for personnel to oversee diagnostic laboratories.
• Adoption of the essential fungal diagnostics for advanced AIDS 
| CON CLUS ION
Poor awareness, lack of skilled personnel and dearth of diagnostic facilities are principal contributors to the scourge of IFIs in Nigeria.
This report has provided an account of the inauguration of the first national society dedicated to medical mycology practice in Africa, the achievements so far and the plans to bring about a renaissance of medical mycology in Nigeria. 
ORCID

